Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Outcome of CYP2D6 Polymorphism on Tramadol Analgesia in Postpartum Patients in Erbil

NCT06814652 is registered in ClinicalTrials.gov with Elweyia Maternity Teaching Hospital as lead sponsor.

NCT NCT06814652
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06814652 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Outcome of CYP2D6 Polymorphism on Tramadol Analgesia in Postpartum Patients in Erbil
Lead sponsor
Elweyia Maternity Teaching Hospital
Phase
Observational
Overall status
Completed
Start date
September 22, 2024
Completion date
April 30, 2025
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cyp2d6 polymorphism, post-cesarean pain, tramadol resistance